于晓玲 - 同济大学

个人简介

中国超声医学工程学会介入超声专委会副主委兼秘书长，中国研究型医院学会肿瘤介入专委会副主委，北京乳腺病防治学会肿瘤免疫治疗专委会副主委，中国超声医学工程学会生物效应专委会副主委，北京亚太肝病诊疗技术联盟肝胆肿瘤专委会副主委，中华医学会超声医学分会介入学组委员兼秘书，海峡两岸医药协会超声医学介入专委会副主委，中国抗癌协会肿瘤影像专委会委员等。课题情况：主持八项国家及军队课题，参与多项国家及军队重大课题，现主持的在研课题经费600余万元基于多维影像大数据智能分析的肝癌个体化微波消融治疗研究，科技部重大专项，2018ZX10723-204，566.66万元，主持，在研基于多模态影像三维导航系统的粒子植入自动化布源规则及方法研究，国家自然科学金，81671710，58万元，主持，在研超声引导三维可视化导航粒子植入治疗系统研发及应用研究，国家自然科学金，81471683，72万元，主持，已结题原发性肝细胞癌微灌注及弹性模量状态与复发机制研究，国家自然科学金，81171358，58万元，主持，已结题基于无创技术的胰腺癌早期诊断的方法学流程及超声检查操作规范，军队重点专项，12BJZ36，30万，主持，已结题获奖情况 2014年获国家技术发明二等奖（第二完成人），题目：微波消融设备的研发与临床应用 2012年获中华医学科技二等奖（第二完成人），题目：微波消融多脏器实体肿瘤的技术创新及应用 2012年获北京市科学技术二等奖（第二完成人），题目：提升微波消融新平台-水冷微波消融系统的研发及其临床应用 2004年获国家科学技术进步二等奖（第三完成人），题目：可控球形热场介入式微波治疗肿瘤技术及肝癌治疗疗效 2015年获实用新型专利一项，名称：一种用于介入手术的电磁定位导航粒子植入套针 2011年获国家发明专利一项，名称：微波消融针及其微波消融治疗仪 2009年获国家发明专利一项，名称：微波功率源及其微波消融治疗仪 2008年获实用新型专利一项，名称：用于915MHz的聚能微波消融针

研究领域

介入超声；肿瘤热消融治疗; 多模态影像引导精准介入诊疗

近期论文

查看导师最新文章（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

Hu Y, Chi C, Wang S, Wang L, Liang P, Liu F, Shang W, Wang W, Zhang F, Li S, Shen H, Yu X*, Liu H, Tian J.A Comparative Study of Clinical Intervention and Interventional Photothermal Therapy for Pancreatic Cancer.Adv Mater. 2017 Sep;29(33). Zhan Y, Zhou F, Yu X*, Luo F, Liu F, Liang P, Cheng Z, Han Z, Yu J. Quantitative dynamic contrast-enhanced ultrasound may help predict the outcome of hepatocellular carcinoma after microwave ablation. Int J Hyperthermia. 2019 Jan 1;35(1):105-111. Li H, Li J, Zhan Y, Han Z, Liu F, Liang P, Yu X*. Ultrasound-Guided 125I Seed Implantation in Treatment of Abdominal Wall Metastases. Cancer Biother Radiopharm. 2019 May;34(4):218-223. Hu Y, Qi E, Liu F, et al. The application of a three-dimensional visualized seed planning and navigation system in125I seed implantation for pancreatic cancer:[J]. Oncotargets Therapy, 2018, 11:619. Zhou F, Shang W, Yu X, et al. Glypican‐3: A promising biomarker for hepatocellular carcinoma diagnosis and treatment[J]. Medicinal Research Reviews, 2017, 38(5). Zhou F, Yu XL, Liang P, Cheng Z, Han ZY, Yu J, Liu F, Hu Y. Microwave ablation is effective against liver metastases from gastric adenocarcinoma. Int J Hyperthermia. 2017 Nov;33(7):830-835 Tan SL, Yu XL, Liang P, Liu F, Cheng Z, Han ZY, Yu J. Preventing intrahepatic infection after ablation of liver tumours in biliary-enteric anastomosis patients. Int J Hyperthermia. 2017 Sep;33(6):664-669. Zhou F, Yu X, Liang P, Han Z, Cheng Z, Yu J, Liu F, Hu Y. Does primary tumor location impact the prognosis of colorectal liver metastases patients after microwave ablation? - Lessons from 10 years' experience. Oncotarget. 2017 Jun 28;8(59); 100791-100800 Sun Y, Zhou F, Liu F, Hu Y, Tan S, Liang P, Linghu E, Yu X. Discrimination of serous cystadenoma from mucinous cystadenoma in the pancreas with contrast-enhanced ultrasonography: a prospective study in 61 patients. Onco Targets Ther. 2017 Feb 28;10:1285-1294. Zhou F, Yu X, Liang P, Cheng Z, Han Z, Yu J, Liu F, Tan S, Dai G, Bai L. Combined microwave ablation and systemic chemotherapy for liver metastases from oesophageal cancer: Preliminary results and literature review. Int J Hyperthermia. 2016;32(5):524-30. Li M, Li Z, Yu X, Liang P, Gao Y, Han Z, Liu F, Dong J. Percutaneous radio-frequency ablation of hepatocellular carcinoma adjacent to the gastrointestinal tract. Int J Hyperthermia. 2016;32(6):600-6. Li M, Yu X, Liang P, Dong B, Liu F. Ultrasound-guided percutaneous microwave ablation for hepatic malignancy adjacent to the gallbladder. Int J Hyperthermia. 2015 Sep;31(6):579-87. Wei Y, Yu XL, Liang P, Cheng ZG, Han ZY, Liu FY, Yu J. Guiding and controlling percutaneous pancreas biopsies with contrast-enhanced ultrasound: target lesions are not localized on B-mode ultrasound. Ultrasound Med Biol. 2015 Jun;41(6):1561-9 Zhang D, Xie D, Wei X, Zhang D, Chen M, Yu X, Liang P. Microwave ablation of the liver abutting the stomach: insulating effect of a chitosan-based thermosensitive hydrogel.Int J Hyperthermia. 2014 Mar;30(2):126-33. Liu LP, Yu XL, Liang P, Dong BW. Characterization of primary hepatic carcinosarcoma by contrast-enhanced ultrasonography: a case report. World J Gastroenterol. 2014 Feb 14;20(6):1630-4. Cao XL, Li H, Yu XL, Liang P, Dong BW, Fan J, Li M, Liu FY. Predicting early intrahepatic recurrence of hepatocellular carcinoma after microwave ablation using SELDI-TOF proteomic signature. PLoS One. 2013 Dec 13;8(12):e82448. Zhang D, Liang P, Yu X, Cheng Z, Han Z, Yu J, Liu F. The value of artificial pleural effusion for percutaneous microwave ablation of liver tumour in the hepatic dome: a retrospective case-control study.Int J Hyperthermia. 2013 Nov;29(7):663-70. Qu P, Yu X, Liang P, Cheng Z, Han Z, Liu F, Yu J. Contrast-enhanced ultrasound in the characterization of hepatocellular carcinomas treated by ablation: comparison with contrast-enhanced magnetic resonance imaging. Ultrasound Med Biol. 2013 Sep;39(9):1571-9. Li M, Yu XL, Liang P, Liu F, Dong B, Zhou P. Percutaneous microwave ablation for liver cancer adjacent to the diaphragm. Int J Hyperthermia. 2012;28(3):218-26. Liu FY, Yu XL, Liang P, Cheng ZG, Han ZY, Dong BW, Zhang XH. Microwave ablation assisted by a real-time virtual navigation system for hepatocellular carcinoma undetectable by conventional ultrasonography.Eur J Radiol. 2012 Jul;81(7):1455-9. Qi C, Yu XL, Liang P, Cheng ZG, Liu FY, Han ZY, Yu J. Ultrasound-guided microwave ablation for abdominal wall metastatic tumors: a preliminary study. World J Gastroenterol. 2012 Jun 21;18(23):3008-14. Liu F, Yu X, Liang P, Cheng Z, Han Z, Dong B. Contrast-enhanced ultrasound-guided microwave ablation for hepatocellular carcinoma inconspicuous on conventional ultrasound. Int J Hyperthermia. 2011;27(6):555-62. Liu FY, Yu XL, Liang P, Wang Y, Zhou P, Yu J. Comparison of percutaneous 915 MHz microwave ablation and 2450 MHz microwave ablation in large hepatocellular carcinoma. Int J Hyperthermia. 2010;26(5):448-55. Liu LP, Dong BW, Yu XL, Liang P, Zhang DK, An LC. Focal hypoechoic tumors of Fatty liver: characterization of conventional and contrast-enhanced ultrasonography.J Ultrasound Med. 2009 Sep;28(9):1133-42.